Summary of Changes
Gestational trophoblastic tumors are effectively treated with chemotherapy even when widely metastatic so that traditional anatomic staging parameters do not adequately provide different prognostic categories. For this reason, although the anatomic categories are preserved, a scoring system of other non-anatomic risk factors has been added. This risk factor score provides the basis for substaging patients into A (low risk, score of 7 or less) or B (high risk, score of 8 or greater).
The “Risk Factors” portion of the stage grouping has been revised to reflect the new scoring system.
Preview
Unable to display preview. Download preview PDF.
Bibliography
Horn LC, Bilek K: Histologic classification and staging of gestational trophoblastic disease. Gen Diagn Pathol 143: 87–101, 1997
Lage JM: Protocol for the examination of specimens from patients with gestational trophoblastic malignancies: a basis for checklists. Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 123: 50–54, 1999
Ngan HYS, Odicino F, Maisonneuve P, et al: Gestational trophoblastic diseases. FIGO Annual Report. J Epidem Biostat 6: 175–184, 2001f
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
American Joint Committee on Cancer. (2002). Gestational Trophoblastic Tumors. In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_32
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3656-4_32
Publisher Name: Springer, New York, NY
Print ISBN: 978-3-540-00595-7
Online ISBN: 978-1-4757-3656-4
eBook Packages: Springer Book Archive